Michael Cunyuan Chen
Chief Scientific Officer · Seaport Therapeutics, Inc.
Individual
- 2026
- May 4, 2026
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Michael Cunyuan Chen files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- ARCH Venture Partners XII, LLC - $19.80M in SPTX purchases and sales in the last 12 months
- Robert J. Hombach - $236K in SPTX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Michael Cunyuan Chen?
Michael Cunyuan Chen is a corporate insider, tracked as Chief Scientific Officer of Seaport Therapeutics, Inc. (SPTX). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Michael Cunyuan Chen last file a Form 4?
The only primary Form 4 on record is dated 4 May 2026.
